Plasminogen activating inhibitor‐1 promotes angiogenesis in cutaneous angiosarcomas
Sign Up to like & getrecommendations! Published in 2022 at "Experimental Dermatology"
DOI: 10.1111/exd.14681
Abstract: Plasminogen activating inhibitor‐1 (PAI‐1) is associated with poor clinical outcomes, and elevated levels of PAI‐1 in both tissue and serum are correlated with poor response to therapy in various cancers, including skin cancer. Cutaneous angiosarcoma… read more here.
Keywords: activating inhibitor; plasminogen activating; promotes angiogenesis; pai ... See more keywords